Overview

Japanese Study Evaluating Safety, Efficacy and Acceptability of Telithromycin in Children With Infections

Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The primary objective is to assess the safety of telithromycin (HMR 3647) (20% fine granules) 1g filling sachet in children with infections (Respiratory tract infections, Dermatological infections, Otorhinolaryngological infections, Dentistry/Oral surgery infections). Secondary objectives are to assess the clinical efficacy, bacteriological efficacy and acceptability of telithromycin (20% fine granules) 1g filling sachet in children with infections.
Phase:
Phase 3
Details
Lead Sponsor:
Sanofi
Treatments:
Telithromycin